Author

Fatemeh Pashizeh

Institutions: Shahid Sadoughi University of Medical Sciences and Health Services, Macquarie University

Observed institutions: Iran University of Medical Sciences, Shahid Sadoughi University of Medical Sciences and Health Services, Kurdistan University of Medical Sciences, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University, Shahid Beheshti University of Medical Sciences, Tehran University of Medical Sciences, Macquarie University

ORCID: 0009-0009-4971-4614

Observed ORCID: 0009-0009-4971-4614

OpenAlex ID: A5088311345

RETRACTED: Co-encapsulation of hydrophilic and hydrophobic drugs into niosomal nanocarrier for enhanced breast cancer therapy: In silico and in vitro studies

2023 · Sahar Amiri, Fatemeh Pashizeh, et al. · Environmental Research · 34

Bioresponsive gingerol-loaded alginate-coated niosomal nanoparticles for targeting intracellular bacteria and cancer cells

2023 · Fatemeh Pashizeh, Afsoun Mansouri, et al. · International Journal of Biological Macromolecules · 29

RETRACTED: 3D Printing of Alginate/Chitosan-Based Scaffold Empowered by Tyrosol-Loaded Niosome for Wound Healing Applications: In Vitro and In Vivo Performances

2024 · Farzaneh Mahmoudi Beram, Saba Naeimaei Ali, et al. · ACS Applied Bio Materials · 23

Alterations of CD4+T Cell Subsets in Blood and Peritoneal Fluid in Different Stages of Endometriosis.

2020 · Fatemeh Pashizeh, Reza Mansouri, et al. · PubMed · 18

UBE2C : A pan‐cancer diagnostic and prognostic biomarker revealed through bioinformatics analysis

2024 · Pooya Jalali, Amir Samii, et al. · Cancer Reports · 9

Association analysis of C677T and A1298C polymorphisms in MTHFR gene in patients with colorectal cancer susceptibility

2021 · Ramin Lak, Elham Kazemi, et al. · 7

Detailed pathological role of non-coding RNAs (ncRNAs) in regulating drug resistance of glioblastoma, and update

2024 · Foad Rahmanpour Leili, Niloofar Shali, et al. · Pathology - Research and Practice · 2

Diabetic retinopathy: mechanisms, and upcoming biomarkers

2021 · Muhammed Furkan Ercisli, Toktam Sadat Tavabe Ghavami, et al. · 2

Breast Cancer Subtyping by Surface-Enhanced Raman Scattering (SERS) Signature of Plasma-Derived Extracellular Vesicles

2026 · Fatemeh Pashizeh, Anastasiia Tukova, et al. · Journal of Analysis and Testing

Small Extracellular Vesicles in Triple-Negative Breast Cancer: From Immune Checkpoint Modulation to Clinical Applications

2026 · Fatemeh Pashizeh, Victoria Ie Ching Tan, et al. · ACS Nano Medicine

Retraction notice to “Co-encapsulation of hydrophilic and hydrophobic drugs into niosomal nanocarrier for enhanced breast cancer therapy: In silico and in vitro studies” [Environ. Res. 239 (2023) 117292]

2026 · Sahar Amiri, Fatemeh Pashizeh, et al. · Environmental Research

Retraction of “3D Printing of Alginate/Chitosan-Based Scaffold Empowered by Tyrosol-Loaded Niosome for Wound Healing Applications: In Vitro and In Vivo Performances”

2024 · Farzaneh Mahmoudi Beram, Saba Naeimaei Ali, et al. · ACS Applied Bio Materials

Ubiquitin-conjugating enzyme 2C (UBE2C) plays as a cancer diagnostic and prognostic marker: A Bioinformatics pan-cancer analysis

2023 · Pooya Jalali, Amir Samei, et al. · Research Square

Works count: 13

Citation count: 124

H-index: 6

I10-index: 4